Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Akira Yuasa"'
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 5, Pp 1105-1125 (2024)
Abstract Introduction Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. However, there is limited evidence assessing the AMR burden in Japan. Thus, this systematic literature review (SLR
Externí odkaz:
https://doaj.org/article/b76a7bccc3b04161839da4985e51c3de
Autor:
Motoyuki Sugai, Akira Yuasa, Ryan L. Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Amer Taie, Jason P. Gordon, Tetsuya Matsumoto
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 6, Pp 1695-1713 (2023)
Abstract Introduction While incidence rates of vancomycin-resistant Enterococcus faecium have remained comparatively low in Japan, there have been increasing reports of more vancomycin-resistant Enterococcus (VRE) outbreaks, requiring costly measures
Externí odkaz:
https://doaj.org/article/f5ba9c1127d14ab28b3459ae4371dac3
Autor:
Motoyuki Sugai, Akira Yuasa, Ryan L. Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Amer Taie, Jason P. Gordon, Tetsuya Matsumoto
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 8, Pp 2191-2192 (2023)
Externí odkaz:
https://doaj.org/article/e1caf29fd7a74f538e87a995c81d9c46
Autor:
Tetsuya Matsumoto, Oliver Darlington, Ryan Miller, Jason Gordon, Phil McEwan, Takahisa Ohashi, Amer Taie, Akira Yuasa
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 8, Iss 2 (2021)
**Background:** Antimicrobial resistance (AMR) represents a significant global public health crisis. Despite ample availability of Gram-positive antibiotics, there is a distinct lack of agents against Gram-negative pathogens, including carbapenem-res
Externí odkaz:
https://doaj.org/article/5fc2e2daec5e4d05be397da8d879db69
Publikováno v:
SAGE Open Medicine, Vol 7 (2019)
Objectives: This study aimed to determine the patient characteristics, treatment procedures, and medical costs of methicillin-resistant Staphylococcus aureus infections in clinical practice in Japan. Methods: Using the MinaCare database of healthcare
Externí odkaz:
https://doaj.org/article/036388bfdfcc4813b97ee9cfde8e3771
Autor:
Taku Kobayashi, Masato Hoshi, Akira Yuasa, Shoko Arai, Mitsunobu Ikeda, Hiroyuki Matsuda, Seok-Won Kim, Toshifumi Hibi
Publikováno v:
PharmacoEconomics. 41:589-604
Autor:
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi, Michael LoPresti, Ankush Taneja, Jake Horgan, Shunya Ikeda
Publikováno v:
Advances in Therapy. 39:5327-5350
In light of the lack of an agreed international standard for how to conduct cost-effectiveness analyses (CEAs), including cost-utility analyses (CUAs) from a societal perspective, there is uncertainty regarding to what extent the inclusion of product
Autor:
Tetsuya Matsumoto, Akira Yuasa, Ryan Miller, Clive Pritchard, Takahisa Ohashi, Amer Taie, Jason Gordon
Publikováno v:
PharmacoEconomics - Open. 7:65-76
Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. Globally, research and development of new antimicrobials has stalled due to unfavorable market conditions, which undervalue antimicrobia
Autor:
Atsuyuki Igarashi, Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Michael LoPresti, Toshiaki Murofushi, Shunya Ikeda
Publikováno v:
Dermatology and Therapy. 12:1729-1751
Psoriasis (PSO), atopic dermatitis (AD), and chronic urticaria (CU) are common manifestations of immunological skin and subcutaneous conditions and have been shown to have a substantial impact on the quality of life of patients. The cost of treating
Autor:
Akira Yuasa, Phil McEwan, Oliver Darlington, Ryan Miller, Takahisa Ohashi, Tetsuya Matsumoto, Amer Taie, Jason Gordon
Publikováno v:
Journal of Health Economics and Outcomes Research
Journal of Health Economics and Outcomes Research (2021)
Journal of Health Economics and Outcomes Research (2021)
Background: Antimicrobial resistance (AMR) represents a significant global public health crisis. Despite ample availability of Gram-positive antibiotics, there is a distinct lack of agents against Gram-negative pathogens, including carbapenem-resista